| 1 |
Querol L , Crabtree M , Herepath M , Priedane E , Viejo Viejo I , Agush S , Sommerer P . Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP). J Neurol, 2021, 268: 3706- 3716.
doi: 10.1007/s00415-020-09998-8
|
| 2 |
Dalakas MC , Medscape . Advances in the diagnosis, pathogenesis and treatment of CIDP. Nat Rev Neurol, 2011, 7: 507- 517.
|
| 3 |
Fehmi J , Bellanti R , Misbah SA , Bhattacharjee A , Rinaldi S . Treatment of CIDP. Pract Neurol, 2023, 23: 46- 53.
doi: 10.1136/pn-2021-002991
|
| 4 |
Vallat JM , Sommer C , Magy L . Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition. Lancet Neurol, 2010, 9: 402- 412.
doi: 10.1016/S1474-4422(10)70041-7
|
| 5 |
Nagamatsu M , Terao S , Misu K , Li M , Hattori N , Ichimura M , Sakai M , Yamamoto H , Watanabe H , Riku S , Ikeda E , Hata J , Oda M , Satake M , Nakamura N , Matsuya S , Hashizume Y , Sobue G . Axonal and perikaryal involvement in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry, 1999, 66: 727- 733.
doi: 10.1136/jnnp.66.6.727
|
| 6 |
Dyck PJB , Tracy JA . History, diagnosis, and management of chronic inflammatory demyelinating polyradiculoneuropathy. Mayo Clin Proc, 2018, 93: 777- 793.
doi: 10.1016/j.mayocp.2018.03.026
|
| 7 |
Sommer C , Koch S , Lammens M , Gabreels-Festen A , Stoll G , Toyka KV . Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP. Neurology, 2005, 65: 1924- 1929.
doi: 10.1212/01.wnl.0000188879.19900.b7
|
| 8 |
Kanda T , Numata Y , Mizusawa H . Chronic inflammatory demyelinating polyneuropathy: decreased claudin-5 and relocated ZO-1. J Neurol Neurosurg Psychiatry, 2004, 75: 765- 769.
doi: 10.1136/jnnp.2003.025692
|
| 9 |
Kiefer R , Kieseier BC , Stoll G , Hartung HP . The role of macrophages in immune-mediated damage to the peripheral nervous system. Prog Neurobiol, 2001, 64: 109- 127.
doi: 10.1016/S0301-0082(00)00060-5
|
| 10 |
Querol L , Lleixà C . Novelimmunological and therapeutic insights in Guillain-Barré syndrome and CIDP. Neurotherapeutics, 2021, 18: 2222- 2235.
doi: 10.1007/s13311-021-01117-3
|
| 11 |
Kiefer R , Dangond F , Mueller M , Toyka KV , Hafler DA , Hartung HP . Enhanced B7 costimulatory molecule expression in inflammatory human sural nerve biopsies. J Neurol Neurosurg Psychiatry, 2000, 69: 362- 368.
doi: 10.1136/jnnp.69.3.362
|
| 12 |
Hu W , Janke A , Ortler S , Hartung HP , Leder C , Kieseier BC , Wiendl H . Expression of CD28-related costimulatory molecule and its ligand in inflammatory neuropathies. Neurology, 2007, 68: 277- 282.
doi: 10.1212/01.wnl.0000250240.99311.9d
|
| 13 |
Tang L , Huang Q , Qin Z , Tang X . Distinguish CIDP with autoantibody from that without autoantibody: pathogenesis, histopathology, and clinical features. J Neurol, 2021, 268: 2757- 2768.
doi: 10.1007/s00415-020-09823-2
|
| 14 |
Kuwabara S , Misawa S , Mori M . Nodopathy: chronic inflammatory demyelinating polyneuropathy with anti-neurofascin 155 antibodies. J Neurol Neurosurg Psychiatry, 2017, 88: 459.
doi: 10.1136/jnnp-2016-315170
|
| 15 |
Yeh WZ , Dyck PJ , van den Berg LH , Kiernan MC , Taylor BV . Multifocal motor neuropathy: controversies and priorities. J Neurol Neurosurg Psychiatry, 2020, 91: 140- 148.
doi: 10.1136/jnnp-2019-321532
|
| 16 |
Wurster C , Petri S . Progress in spinal muscular atrophy research. Curr Opin Neurol, 2022, 35: 693- 698.
doi: 10.1097/WCO.0000000000001102
|
| 17 |
Ansari AF , Jagiasi K , Ojha P , Ansari R , Nagendra S , Kharat S . Proximal dominant hereditary motor and sensory neuropathy withtfgmutation: first case report from India. Neurol India, 2022, 70: 1220- 1222.
doi: 10.4103/0028-3886.349586
|
| 18 |
Tartara E , Fanucchi S , D'Errico I , Farina LM , Casoni F , Sinforiani E , Micieli G , Costa A . A case of Wernicke encephalopathy combined with disulfiram intoxication. Cogn Behav Neurol, 2013, 26: 93- 98.
doi: 10.1097/WNN.0b013e31829b7a6b
|
| 19 |
Seeliger T , Gingele S , Bönig L , Konen FF , Körner S , Prenzler N , Thiele T , Ernst D , Witte T , Stangel M , Skripuletz T . CIDP associated with Sjögren's syndrome. J Neurol, 2021, 268: 2908- 2912.
doi: 10.1007/s00415-021-10459-z
|
| 20 |
Julio PR , Cortês MMM , Costallat LTL , Gaino JZ , França MC Jr , Appenzeller S . Chronic inflammatory demyelinating polyradiculoneuropathy associated with systemic lupus erythematosus. Semin Arthritis Rheum, 2021, 51: 158- 165.
doi: 10.1016/j.semarthrit.2020.09.018
|
| 21 |
Van den Bergh PYK , van Doorn PA , Hadden RDM , Avau B , Vankrunkelsven P , Allen JA , Attarian S , Blomkwist-Markens PH , Cornblath DR , Eftimov F , Goedee HS , Harbo T , Kuwabara S , Lewis RA , Lunn MP , Nobile-Orazio E , Querol L , Rajabally YA , Sommer C , Topaloglu HA . European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision. J Peripher Nerv Syst, 2021, 26: 242- 268.
doi: 10.1111/jns.12455
|
| 22 |
Galleguillos D , Wang Q , Steinberg N , Zaidi A , Shrivastava G , Dhami K , Daskhan GC , Schmidt EN , Dworsky-Fried Z , Giuliani F , Churchward M , Power C , Todd K , Taylor A , Macauley MS , Sipione S . Anti-inflammatory role of GM1 and other gangliosides on microglia. J Neuroinflammation, 2022, 19: 9.
doi: 10.1186/s12974-021-02374-x
|
| 23 |
Cao S , Hu X , Ren S , Wang Y , Shao Y , Wu K , Yang Z , Yang W , He G , Li X . The biological role and immunotherapy of gangliosides and GD3 synthase in cancers. Front Cell Dev Biol, 2023, 11: 1076862.
doi: 10.3389/fcell.2023.1076862
|
| 24 |
Azzaz F , Yahi N , Di Scala C , Chahinian H , Fantini J . Ganglioside binding domains in proteins: physiological and pathological mechanisms. Adv Protein Chem Struct Biol, 2022, 128: 289- 324.
|
| 25 |
Goodfellow JA , Willison HJ . Antiganglioside, antiganglioside-complex, and antiglycolipid-complex antibodies in immune-mediated neuropathies. Curr Opin Neurol, 2016, 29: 572- 580.
doi: 10.1097/WCO.0000000000000361
|
| 26 |
Li Z , Zhang Q . Ganglioside isomer analysis using ion polarity switching liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem, 2021, 413: 3269- 3279.
doi: 10.1007/s00216-021-03262-2
|
| 27 |
Caudie C , Quittard Pinon A , Taravel D , Sivadon-Tardy V , Orlikowski D , Rozenberg F , Sharshar T , Raphaël JC , Gaillard JL . Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain-Barré syndrome patients. J Neurol, 2011, 258: 1958- 1964.
doi: 10.1007/s00415-011-6042-9
|
| 28 |
Latov N . Campylobacter jejuniinfection, anti-ganglioside antibodies, and neuropathy. Microorganisms, 2022, 10: 2139.
doi: 10.3390/microorganisms10112139
|
| 29 |
Ngamukote S , Yanagisawa M , Ariga T , Ando S , Yu RK . Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains. J Neurochem, 2007, 103: 2327- 2341.
doi: 10.1111/j.1471-4159.2007.04910.x
|
| 30 |
Wang J , Yu RK . Interaction of ganglioside GD3 with an EGF receptor sustains the self-renewal ability of mouse neural stem cells in vitro. Proc Natl Acad Sci USA, 2013, 110: 19137- 19142.
doi: 10.1073/pnas.1307224110
|
| 31 |
Lopez PHH , Báez BB . Gangliosides inaxon stability and regeneration. Prog Mol Biol Transl Sci, 2018, 156: 383- 412.
|
| 32 |
Tang FL , Wang J , Itokazu Y , Yu RK . Ganglioside GD3 regulates dendritic growth in newborn neurons in adult mouse hippocampus via modulation of mitochondrial dynamics. J Neurochem, 2021, 156: 819- 833.
doi: 10.1111/jnc.15137
|
| 33 |
Wanleenuwat P , Iwanowski P , Kozubski W . Antiganglioside antibodies in neurological diseases. J Neurol Sci, 2020, 408: 116576.
doi: 10.1016/j.jns.2019.116576
|
| 34 |
Franciotta D , Gastaldi M , Benedetti L , Pesce G , Biagioli T , Lolli F , Costa G , Melis C , Andreetta F , Simoncini O , Giannotta C , Bazzigaluppi E , Fazio R , Bedin R , Ferraro D , Mariotto S , Ferrari S , Galloni E , De Riva V , Zardini E , Cortese A , Nobile-Orazio E . Diagnostics of dysimmune peripheral neuropathies. Neurol Sci, 2017, 38 (Suppl 2): 243- 247.
|
| 35 |
Gómez-Nicola D , Doncel-Pérez E , Nieto-Sampedro M . Regulation by GD3 of the proinflammatory response of microglia mediated by interleukin-15. J Neurosci Res, 2006, 83: 754- 762.
doi: 10.1002/jnr.20777
|
| 36 |
Manganelli V , Matarrese P , Antonioli M , Gambardella L , Vescovo T , Gretzmeier C , Longo A , Capozzi A , Recalchi S , Riitano G , Misasi R , Dengjel J , Malorni W , Fimia GM , Sorice M , Garofalo T . Raft-like lipid microdomains drive autophagy initiation via AMBRA1-ERLIN1 molecular association within MAMs. Autophagy, 2021, 17: 2528- 2548.
doi: 10.1080/15548627.2020.1834207
|
| 37 |
Sindern E , Stark E , Haas J , Steck AJ . Serum antibodies to GM1 and GM3-gangliosides in systemic lupus erythematosus with chronic inflammatory demyelinating polyradiculoneuropathy. Acta Neurol Scand, 1991, 83: 399- 402.
doi: 10.1111/j.1600-0404.1991.tb03971.x
|
| 38 |
Bird SJ , Brown MJ , Shy ME , Scherer SS . Chronic inflammatory demyelinating polyneuropathy associated with malignant melanoma. Neurology, 1996, 46: 822- 824.
doi: 10.1212/WNL.46.3.822
|
| 39 |
Usuki S , Sanchez J , Ariga T , Utsunomiya I , Taguchi K , Rivner MH , Yu RK . AIDP and CIDP having specific antibodies to the carbohydrate epitope (-NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glc-) of gangliosides. J Neurol Sci, 2005, 232: 37- 44.
doi: 10.1016/j.jns.2005.01.007
|
| 40 |
Willison HJ , Almemar A , Veitch J , Thrush D . Acute ataxic neuropathy with cross-reactive antibodies to GD1b and GD3 gangliosides. Neurology, 1994, 44: 2395- 2397.
doi: 10.1212/WNL.44.12.2395
|
| 41 |
Peillet C , Adams D , Attarian S , Bouhour F , Cauquil C , Cassereau J , Chanson JB , Cintas P , Creange A , Delmont E , Fargeot G , Genestet S , Gueguen A , Kaminsky AL , Kuntzer T , Labeyrie C , Michaud M , Pereon Y , Puma A , Viala K , Chretien P , Adam C , Echaniz-Laguna A . Anti-disialosyl-immunoglobulin M chronic autoimmune neuropathies: a nationwide multicenter retrospective study. Eur J Neurol, 2022, 29: 3547- 3555.
doi: 10.1111/ene.15523
|
| 42 |
Svačina MKR , Lehmann HC . Chronic inflammatory demyelinating polyneuropathy (CIDP): current therapies and future approaches. Curr Pharm Des, 2022, 28: 854- 862.
doi: 10.2174/1381612828666220325102840
|
| 43 |
Attarian S , Boucraut J , Hubert AM , Uzenot D , Delmont E , Verschueren A , Franques J , Azulay JP , Pouget J . Chronic ataxic neuropathies associated with anti-GD1b IgM antibodies: response to IVIg therapy. J Neurol Neurosurg Psychiatry, 2010, 81: 61- 64.
doi: 10.1136/jnnp.2009.185736
|